The European Union (EU) and Turkey have a long and multifaceted relationship. In this entry (based on a recent longer analysis) we focus on Turkey’s involvement with the EU’s decentralised agencies, and more particularly on whether and to what extent this involvement can be viewed as a part of a...
The Boards of Appeal established for the decision-making agencies perform a function that lies between exercising administrative review, at the one end, and offering judicial review, at the other. It is still unclear in which direction they will ultimately move, and more research in this fast...
Current US and EU secondary liability standards do not address all factors to trigger liability. This influences legislation and case law, setting an uncertain secondary liability outcome of IP infringement cases against Internet Intermediaries’. I suggest that tort law can tackle this problem.
In recent weeks, the divisions between North and South, as well as the creation of European corona bonds have dominated most European debates. At the same time, there has been contradictory information regarding the financial aid mobilised by Brussels in response to the COVID-19 pandemic. The...
by Trym Nohr Fjørtoft
In 2015, many European states experienced a massive influx of migrants and refugees seeking protection within their borders. The European Refugee crisis was a crisis in many respects—first and foremost for the people forced to flee their homes, but also for the institution...
EU agencies are now at the forefront of policy implementation in EU’s migration, asylum and external border control policies for two primary reasons: to overcome the policy implementation gap and enhance interstate solidarity.
When the three main institutions adopted the Common Approach on EU Decentralised Agencies in 2012 one of the few innovative elements in this otherwise disappointing non-binding interinstitutional agreement were the provisions dedicated to the selection of the seat of EU agencies. As many EU-watchers...
Unlike other sectors, improvements in Genetic technology raise issues of morality. The new human gene editing technology CRISPR/CAS9 has raised many such concerns. Can the current patent system deal with these concerns or should morality be dealt with by the inventors themselves?
The need to guarantee the free flow of information in a Big Data economy forces us to re-think Intellectual Property Rights and find an appropriate balance between competition, innovation, privacy and incentives.
With or without the UK, the EU will try to find a way to implement the UPC as it has invested considerable time and efforts knowing the benefits it will bring; however, the fate of the Agreement could be decided on judicial grounds instead of political ones.
